NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
Unusual Whales
NorthStrive Biosciences has broadened its AI-driven drug discovery program in partnership with Yuva Biosciences. They are progressing four newly discovered compounds through AI toward lead nomination.
